Walmart will sell insulin made by Novo Nordisk under its own private label, and at a lower price, as it continues to push growth in its healthcare business.

Analyst David Risinger expects the Indianapolis firm to post higher revenue and fatter profit margins. And he's optimistic about its diabetes- and psoriasis-treatment offerings.

A report says the biotechnology company is exploring options including a potential sale amid interest from pharmaceutical companies looking to expand in gene therapy.

Gilead Sciences is partnering with Novo Nordisk to help combat liver disease.

Jim Cramer says these downgrades may be well-reasoned, but he wants to know if they're correct.

Jim Cramer weighs in on Ollie's Bargain Outlet, Novo Nordisk, Avnet, Cabot Corp., Helmerich & Payne, Amarin, Golar LNG, Nio and more.

Global stocks were mixed Wednesday, with stronger-than-expected trade data from China, as well as the expectation of further stimulus from Beijing, boosting shares in Asia while softer earnings in Europe held down gains for stocks on the Continent.

Insulin has been around since 1921. But there is no generic drug and four companies control the market. Now politicians, the AMA and patient groups are looking for lower prices.

Pharma firm's new diabetes drug showed positive test results.

The billionaire and crypto investor was in business with Voyager Digital which went bankrupt early July.

The builder confidence index breached the break-even measure of 50 in August for the first time since May 2020.

China is a crucial country for Tesla for its domination of the market of electric vehicles.